Back to search results

A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype

Abroad (travel likely)RecruitingPHASE3

Conditions

Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Universitair Ziekenhuis Gent (UZ Gent), Ghent, Belgium

    Study coordinator · Ciel.DeVriendt@uzgent.be
    Contact: Principal Investigator (Ciel Vriendt)

  • UZ Leuven - Gasthuisberg Campus, Leuven, Belgium

    Study coordinator · koen.debackere@uzleuven.be
    Contact: Principal Investigator (Koen Debackere)

  • Vseobecna fakultni nemocnice, Prague, Czechia

    Study coordinator · trneny@cesnet.cz
    Contact: Principal Investigator (Marek Trneny)

  • Aarhus University Hospital, Aarhus, Denmark

    Study coordinator · frandamo@rm.dk
    Contact: Principal Investigator (Francesco A D'Amore)

  • Rigshospitalet Copenhagen, Copenhagen, Denmark

    Study coordinator · peter.brown@regionh.dk
    Contact: Principal Investigator (Peter Brown)

  • Odense Hospital, Odense, Denmark

    Study coordinator · Peter.Braendstrup@rsyd.dk
    Contact: Principal Investigator (Peter Braendstrup)

  • UNICANCER - Centre Henri-Becquerel, Rouen, Normandy, France

    Study coordinator · vincent.camus@chb.unicancer.fr
    Contact: Principal Investigator (Vincent Camus)

  • Institut Gustave Roussy, Villejuif, Vaillant, France

    Study coordinator · vincent.ribrag@gustaveroussy.fr
    Contact: Principal Investigator (Vincent Ribrag)

  • CHU Cote de Nacre, Caen, France

    Study coordinator · damaj-gl@chu-caen.fr
    Contact: Principal Investigator (Gandhi Damaj)

  • CHU Clermont-Ferrand, Clermont-Ferrand, France

    Study coordinator · otournilhac@chu-clermontferrand.fr
    Contact: Principal Investigator (Olivier Tournilhac)

  • CHU Montpellier, Montpellier, France

    Study coordinator · g-cartron@chu-montpellier.fr
    Contact: Principal Investigator (Guillaume Cartron)

  • CHU Nantes, Nantes, France

    Study coordinator · benoit.tessoulin@chu-nantes.fr
    Contact: Principal Investigator (Benoît Tessoulin)

  • Hopital Pitie Salpetriere, Paris, France

    Study coordinator · marine.baron@aphp.fr
    Contact: Principal Investigator (Marine Baron)

  • CHU Bordeaux, Pessac, France

    Study coordinator · krimo.bouabdallah@chu-bordeaux.fr
    Contact: Principal Investigator (Krimo Bouabdallah)

  • Centre Hospitalier Lyon Sud, Pierre-Bénite, France

    Study coordinator · emmanuel.bachy@chu-lyon.fr
    Contact: Principal Investigator (Emmanuel Bachy)

  • CHU PONTCHAILLOU-Haematology, Rennes, France

    Study coordinator · Roch.HOUOT@chu-rennes.fr
    Contact: Principal Investigator (Roch Houot)

  • Institut Curie Paris, Saint-Cloud, France

    Study coordinator · carole.soussain@curie.fr
    Contact: Principal Investigator (Carole Soussain)

  • Evangelisches Krankenhaus Essen-Werden, Essen, Germany

    Study coordinator · p.reimer@kem-med.com
    Contact: Principal Investigator (Peter Reimer)

  • Universitaetsmedizin Goettingen (UMG) - Klinik fuer Haematologie und Medizinische Onkologie, Goettigen, Germany

    Study coordinator · raphael.koch@med.uni-goettingen.de
    Contact: Principal Investigator (Raphael Koch)

  • Universitaetsklinikum Halle (Saale), Halle, Germany

    Study coordinator · thomas.weber@uk-halle.de
    Contact: Principal Investigator (Thomas Weber)

  • Universitaetsklinikum Leipzig- Klinik und Poliklinik fuer Haematologie und Zelltherapie, Leipzig, Germany

    Study coordinator · marco.herling@medizin.uni-leipzig.de
    Contact: Principal Investigator (Marco Herling)

  • Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo - Alessandria, Alessandria, Italy

    Study coordinator · manuela.zanni@ospedale.al.it
    Contact: Principal Investigator (Manuela Zanni)

  • Asst Papa Giovanni Xxiii Uo Ematologia, Bergamo, Italy

    Study coordinator · g.gritti@asst-pg23.it
    Contact: Principal Investigator (Giuseppe Gritti)

  • Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

    Study coordinator · pierluigi.zinzani@unibo.it
    Contact: Principal Investigator (Pier Luigi Zinzani)

  • Ematologia Oncologia Instituto Pascale, Naples, Italy

    Study coordinator · a.pinto@istitutotumori.na.it
    Contact: Principal Investigator (Antonello Pinto)

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

    Study coordinator · stefan.hohaus@policlinicogemelli.it
    Contact: Principal Investigator (Stefan Hohaus)

  • Amsterdam UMC location AMC, Amsterdam, Netherlands

    Study coordinator · ilse.kuipers@amsterdamumc.nl
    Contact: Principal Investigator (Ilse Kuipers)

  • Leiden University Medical Center (LUMC), Leiden, Netherlands

    Study coordinator · j.s.p.vermaat@lumc.nl
    Contact: Principal Investigator (Joost Vermaat)

  • Erasmus University Medical Center, Rotterdam, Netherlands

    Study coordinator · y.serroukh@erasmusmc.nl
    Contact: Principal Investigator (Yasmina Serroukh)

  • Uniwersyteckie Centrum Kliniczne Oddzial Hematologii i Transplantologii, Gdansk, Poland

    Study coordinator · jan.zaucha@gumed.edu.pl
    Contact: Principal Investigator (Jan Zaucha)

  • Pratia Centrum Medyczne Krakow, Krakow, Poland

    Study coordinator · wojciech.jurczak@lymphoma.edu.pl
    Contact: Principal Investigator (Wojciech Jurczak)

  • Instytut Hematologii i Transfuzjologii, Warsaw, Poland

    Study coordinator · akolkowska@ihit.waw.pl
    Contact: Principal Investigator (Agnieszka Kolkowska-Lesiak)

  • Narodowy Instytut Onkologii im. Marii Skłodowskiej - Curie, Warsaw, Poland

    Study coordinator · joanna.romejko-jarosinska@nio.gov.pl
    Contact: Principal Investigator (Joanna Romejko-Jarosinska)

  • ICO Hospitalet (Hospital Duran i Reynals), Barcelona, Spain

    Study coordinator · edomingo@iconcologia.net
    Contact: Principal Investigator (Eva Domingo Domenech)

  • Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain

    Study coordinator · sergio.ramos@quironsalud.es
    Contact: Principal Investigator (Sergio Ramos)

  • Hospital Clinico Universitario de Salamanca, Salamanca, Spain

    Study coordinator · amartingar@usal.es
    Contact: Principal Investigator (Alejandro Martin Garcia-Sancho)

  • Hospital Universitario Virgen del Rocio, Seville, Spain

    Study coordinator · fatimadelacruzv@gmail.com
    Contact: Principal Investigator (Fatima de la Cruz)

  • The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

    Study coordinator · dima.el-sharkawi@rmh.nhs.uk
    Contact: Principal Investigator (Dima El-Sharkawi)

  • Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

    Study coordinator · Matthew.Wilson@ggc.scot.nhs.uk
    Contact: Principal Investigator (Matthew Wilson)

  • University Hospitals of Leicester NHS Trust, Leicester, United Kingdom

    Study coordinator · mja40@leicester.ac.uk
    Contact: Principal Investigator (Matthew Ahearne)

  • UCLH NHS Foundation Trust, London, United Kingdom

    Study coordinator · kate.cwynarski@nhs.net
    Contact: Principal Investigator (Kate Cwynarski)

  • The Christie NHS Foundation Trust, Manchester, United Kingdom

    Study coordinator · tim.illidge@manchester.ac.uk · 0161 446 3332
    Contact: Principal Investigator (Timothy Illidge)

  • Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

    Study coordinator · christopher.fox@nhs.net
    Contact: Principal Investigator (Christopher Fox)

  • Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

    Study coordinator · graham.collins@ouh.nhs.uk
    Contact: Principal Investigator (Graham Collins)
View source on ClinicalTrials.gov(opens in a new tab)